Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Total lymphoid irradiation in multiple sclerosis

C M Wiles1, L Omar, A V Swan

  • 1Department of Neurology, St Thomas's Hospital, London, UK.

Journal of Neurology, Neurosurgery, and Psychiatry
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproducibility of semi-quantitative assessment of aortic valve calcification and valve motion on echocardiography: a small-scale study.

Echo research and practice·2024
Same author

Homeworking among healthcare workers during the COVID-19 pandemic.

Occupational medicine (Oxford, England)·2024
Same author

Serpiginous-like choroiditis as sign of intraocular tuberculosis.

Journal francais d'ophtalmologie·2019
Same author

Intense visible emission from ZnO/PAAX (X = H or Na) nanocomposite synthesized via a simple and scalable sol-gel method.

Scientific reports·2016
Same author

Sero-prevalence of avian influenza in animals and human in Egypt.

Pakistan journal of biological sciences : PJBS·2014
Same author

A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial.

British journal of cancer·2011

Total lymphoid irradiation (TLI) did not show significant clinical benefits for chronic progressive multiple sclerosis. While TLI impacted T lymphocytes and MRI lesions, it did not improve disease progression, with increased side effects noted.

Area of Science:

  • Immunology
  • Neurology
  • Radiotherapy

Background:

  • Total lymphoid irradiation (TLI) showed prior efficacy in treating chronic progressive multiple sclerosis.
  • A randomized, double-blind, placebo-controlled study was designed to further investigate TLI's efficacy.

Purpose of the Study:

  • To evaluate the clinical efficacy of total lymphoid irradiation (TLI) in patients with chronic progressive multiple sclerosis.
  • To assess TLI's impact on disease progression, disability, and MRI findings.

Main Methods:

  • 27 patients were recruited over 2.5 years; 14 received active TLI (1980 cGy) and 10 received sham treatment.
  • Primary outcome: change in Expanded Kurtzke Disability Scale (EDSS) over two years.
  • Secondary outcomes: psychometry, bladder function, MRI brain scans, and visual analogue scales.

Related Experiment Videos

Main Results:

  • TLI induced a significant decrease in T lymphocytes (CD4+) and reversed the CD4:CD8 ratio.
  • No significant difference in EDSS-based clinical disease progression between groups.
  • A minor benefit in bladder function and a small, significant reduction in new MRI brain lesions were observed.

Conclusions:

  • TLI did not confirm previous clinical benefits for chronic progressive multiple sclerosis.
  • A modest beneficial effect on MRI lesion accumulation suggests potential for further immune modulation research.
  • TLI is not recommended for routine treatment due to limited efficacy and increased side effects.